TGTX logo

TG Therapeutics (TGTX) CAPEX

Annual CAPEX

N/A

31 December 2023

All-time High

$401.00 K
TGTX annual capital expenditures is currently at an all-time high
Annual FCF-$31.41 M
TGTX annual free cash flow is -$31.41 million
Annual CFO-$31.41 M
TGTX annual cash flow from operations is -$31.41 million
Annual CFI-$50.65 M
TGTX annual cash flow from investing activities is -$50.65 million
Annual CFF$72.70 M
TGTX annual cash flow from financing activities is $72.70 million

TGTX CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

$24.00 K
0.00%

30 September 2024

3-Year Change

-69.62%
TGTX quarterly capital expenditures is down -69.62% over the past 3 years

All-time High

$282.30 K
TGTX quarterly capital expenditures is currently -91.50% below its historical high of $282.30 thousand

Sector Rank

17.93%
TGTX quarterly capital expenditures is higher than 17.93% of companies in Healthcare sector
Quarterly FCF-$12.23 M
TGTX quarterly free cash flow is -$12.23 million
Quarterly CFO-$12.21 M
TGTX quarterly cash flow from operations is -$12.21 million
Quarterly CFI-$9.33 M
TGTX quarterly cash flow from investing activities is -$9.33 million
Quarterly CFF$134.45 M
TGTX quarterly cash flow from financing activities is $134.45 million

TGTX Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

$24.00 K
0.00%

30 September 2024

3-Year Change

-94.96%
TGTX TTM capital expenditures is down -94.96% over the past 3 years

All-time High

$486.00 K
TGTX TTM capital expenditures is currently -95.06% below its historical high of $486.00 thousand

Sector Rank

4.59%
TGTX TTM capital expenditures is higher than 4.59% of companies in Healthcare sector
TTM FCF-$28.11 M
TGTX TTM free cash flow is -$28.11 million
TTM CFO-$28.09 M
TGTX TTM cash flow from operations is -$28.09 million
TTM CFI-$61.58 M
TGTX TTM cash flow from investing activities is -$61.58 million
TTM CFF$134.60 M
TGTX TTM cash flow from financing activities is $134.60 million

TGTX TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TGTX CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years--69.6%-95.0%
5 y5 years--63.1%-76.7%

TGTX CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-70.0%-95.0%+71.4%
5 y5 years-86.3%-95.1%+71.4%
alltimeall time-91.5%+241.2%-95.1%

TG Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Sept 2024
-
$24.00 K(+700.0%)
$24.00 K(+71.4%)
Dec 2022
$14.00 K(-96.5%)
$3000.00(-25.0%)
$14.00 K(-84.6%)
Sept 2022
-
$4000.00(>+9900.0%)
$91.00 K(-45.2%)
June 2022
-
$0.00(-100.0%)
$166.00 K(-51.3%)
Mar 2022
-
$7000.00(-91.3%)
$341.00 K(-15.0%)
Dec 2021
$401.00 K(+12.3%)
$80.00 K(+1.3%)
$401.00 K(-15.8%)
Sept 2021
-
$79.00 K(-54.9%)
$476.00 K(-2.1%)
June 2021
-
$175.00 K(+161.2%)
$486.00 K(+36.5%)
Mar 2021
-
$67.00 K(-56.8%)
$356.00 K(-0.3%)
Dec 2020
$357.00 K(+172.5%)
$155.00 K(+74.2%)
$357.00 K(+51.3%)
Sept 2020
-
$89.00 K(+97.8%)
$236.00 K(+11.3%)
June 2020
-
$45.00 K(-33.8%)
$212.00 K(+14.6%)
Mar 2020
-
$68.00 K(+100.0%)
$185.00 K(+41.2%)
Dec 2019
$131.00 K(+45.6%)
$34.00 K(-47.7%)
$131.00 K(+27.2%)
Sept 2019
-
$65.00 K(+261.1%)
$103.00 K(+60.9%)
June 2019
-
$18.00 K(+28.6%)
$64.00 K(-20.0%)
Mar 2019
-
$14.00 K(+133.3%)
$80.00 K(-11.1%)
Dec 2018
$90.00 K(+4400.0%)
$6000.00(-76.9%)
$90.00 K(+7.1%)
Sept 2018
-
$26.00 K(-23.5%)
$84.00 K(+44.8%)
June 2018
-
$34.00 K(+41.7%)
$58.00 K(+123.1%)
Mar 2018
-
$24.00 K(>+9900.0%)
$26.00 K(+1200.0%)
Dec 2017
$2000.00(-99.4%)
$0.00(0.0%)
$2000.00(-91.3%)
Sept 2017
-
$0.00(-100.0%)
$23.00 K(-36.1%)
June 2017
-
$2000.00(-90.5%)
$36.00 K(-89.5%)
Dec 2016
$344.00 K(+715.2%)
$21.00 K(+61.5%)
$344.10 K(+12.4%)
Sept 2016
-
$13.00 K(-53.2%)
$306.10 K(-7.8%)
June 2016
-
$27.80 K(-90.2%)
$332.00 K(+4.5%)
Mar 2016
-
$282.30 K(-1760.6%)
$317.60 K(+652.6%)
Dec 2015
$42.20 K(+126.9%)
-$17.00 K(-143.7%)
$42.20 K(-42.4%)
Sept 2015
-
$38.90 K(+190.3%)
$73.30 K(+105.3%)
June 2015
-
$13.40 K(+94.2%)
$35.70 K(+60.1%)
Mar 2015
-
$6900.00(-51.1%)
$22.30 K(+19.9%)
Dec 2014
$18.60 K(+226.3%)
$14.10 K(+984.6%)
$18.60 K(+169.6%)
Sept 2014
-
$1300.00(>+9900.0%)
$6900.00(-4.2%)
June 2014
-
$0.00(-100.0%)
$7200.00(-19.1%)
Mar 2014
-
$3200.00(+33.3%)
$8900.00(+56.1%)
Dec 2013
$5700.00(+307.1%)
$2400.00(+50.0%)
$5700.00(+72.7%)
Sept 2013
-
$1600.00(-5.9%)
$3300.00(+94.1%)
June 2013
-
$1700.00(>+9900.0%)
$1700.00(+21.4%)
Dec 2012
$1400.00(-50.0%)
$0.00(0.0%)
$1400.00(0.0%)
Sept 2012
-
$0.00(-100.0%)
$1400.00(0.0%)
June 2012
-
$1400.00(>+9900.0%)
$1400.00(-50.0%)
Dec 2010
$2800.00
$0.00(0.0%)
$2800.00(0.0%)
DateAnnualQuarterlyTTM
Sept 2010
-
$0.00(-100.0%)
$2800.00(0.0%)
June 2010
-
$2800.00(>+9900.0%)
$2800.00(-68.9%)
Dec 2008
$9000.00(-1.1%)
$0.00(0.0%)
$9000.00(0.0%)
Sept 2008
-
$0.00(-100.0%)
$9000.00(0.0%)
June 2008
-
$9000.00(>+9900.0%)
$9000.00(-2.2%)
Dec 2007
$9100.00(-75.5%)
$0.00(0.0%)
$9200.00(-69.7%)
Sept 2007
-
$0.00(-100.0%)
$30.40 K(-9.0%)
June 2007
-
$2900.00(-54.0%)
$33.40 K(-4.0%)
Mar 2007
-
$6300.00(-70.3%)
$34.80 K(-5.9%)
Dec 2006
$37.10 K(-6.3%)
$21.20 K(+606.7%)
$37.00 K(+14.9%)
Sept 2006
-
$3000.00(-30.2%)
$32.20 K(+6.6%)
June 2006
-
$4300.00(-49.4%)
$30.20 K(+7.9%)
Mar 2006
-
$8500.00(-48.2%)
$28.00 K(-29.3%)
Dec 2005
$39.60 K(-71.4%)
$16.40 K(+1540.0%)
$39.60 K(+31.1%)
Sept 2005
-
$1000.00(-52.4%)
$30.20 K(-71.6%)
June 2005
-
$2100.00(-89.6%)
$106.50 K(-14.4%)
Mar 2005
-
$20.10 K(+187.1%)
$124.40 K(-10.1%)
Dec 2004
$138.30 K(+1995.5%)
$7000.00(-90.9%)
$138.30 K(+5.3%)
Sept 2004
-
$77.30 K(+286.5%)
$131.30 K(+136.6%)
June 2004
-
$20.00 K(-41.2%)
$55.50 K(+56.3%)
Mar 2004
-
$34.00 K(>+9900.0%)
$35.50 K(+437.9%)
Dec 2003
$6600.00(-93.9%)
$0.00(-100.0%)
$6600.00(+69.2%)
Sept 2003
-
$1500.00(>+9900.0%)
$3900.00(-23.5%)
June 2003
-
$0.00(-100.0%)
$5100.00(0.0%)
Mar 2003
-
$5100.00(-288.9%)
$5100.00(>+9900.0%)
Dec 2002
-
-$2700.00(-200.0%)
$0.00(-100.0%)
Sept 2002
-
$2700.00(>+9900.0%)
$2700.00(-97.5%)
Dec 2001
$108.20 K(-36.9%)
$0.00(-100.0%)
$108.30 K(-23.6%)
Sept 2001
-
$6400.00(-57.9%)
$141.80 K(-43.3%)
June 2001
-
$15.20 K(-82.5%)
$250.10 K(-0.8%)
Mar 2001
-
$86.70 K(+158.8%)
$252.00 K(+47.0%)
Dec 2000
$171.40 K(+71.4%)
$33.50 K(-70.8%)
$171.40 K(+24.3%)
Sept 2000
-
$114.70 K(+570.8%)
$137.90 K(+494.4%)
June 2000
-
$17.10 K(+180.3%)
$23.20 K(+280.3%)
Mar 2000
-
$6100.00(>+9900.0%)
$6100.00(-97.0%)
Dec 1999
$100.00 K(-50.0%)
-
-
Dec 1998
$200.00 K(0.0%)
$0.00(0.0%)
$200.00 K(0.0%)
Sept 1998
-
$0.00(-100.0%)
$200.00 K(-33.3%)
June 1998
-
$100.00 K(0.0%)
$300.00 K(0.0%)
Mar 1998
-
$100.00 K(>+9900.0%)
$300.00 K(+50.0%)
Dec 1997
$200.00 K(+100.0%)
$0.00(-100.0%)
$200.00 K(0.0%)
Sept 1997
-
$100.00 K(0.0%)
$200.00 K(+100.0%)
June 1997
-
$100.00 K
$100.00 K
Dec 1996
$100.00 K
-
-

FAQ

  • What is the all time high annual CAPEX for TG Therapeutics?
  • What is TG Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for TG Therapeutics?
  • What is TG Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for TG Therapeutics?

What is the all time high annual CAPEX for TG Therapeutics?

TG Therapeutics all-time high annual capital expenditures is $401.00 K

What is TG Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of TGTX is $24.00 K

What is the all time high quarterly CAPEX for TG Therapeutics?

TG Therapeutics all-time high quarterly capital expenditures is $282.30 K

What is TG Therapeutics TTM capital expenditures?

The current TTM CAPEX of TGTX is $24.00 K

What is the all time high TTM CAPEX for TG Therapeutics?

TG Therapeutics all-time high TTM capital expenditures is $486.00 K